Oracle’s (ORCL) Has An Enormous Backlog Concentration Risk. Here’s How Healthcare AI Push Could Help Diversify Away

Oracle Corporation (NYSE:ORCL) is one of the 10 Best Major Stocks to Buy According to Analysts. Oracle Corporation (NYSE:ORCL) serves multiple industries, and one example of this was seen on June 24 when it teamed up with Theator. This collaboration will allow the company to provide AI-powered surgical intelligence solutions to Oracle Health customers. The AI technology will reduce documentation errors, improve patient care, and make billing and payment processes more efficient.

Additionally, Theator’s technology uses AI to analyze surgical videos alongside patient health records. This allows surgical teams to automatically generate more accurate clinical and billing documentation while reducing administrative work, the company noted. Moreover, the tech giant said that Theator’s cloud-based surgical platform runs on Oracle Cloud Infrastructure, allowing it to take advantage of OCI’s security and computing power. This partnership highlights ORCL’s strategic transformation from a traditional database company into a dominant, AI-driven cloud provider for specialized industries.

Earlier on June 23, KeyBanc analyst Jackson Ader reaffirmed a Buy rating on Oracle Corporation (NYSE:ORCL) stock and assigned a price target of $300.

Oracle Corporation (NYSE:ORCL) provides information technology-related products and services to enterprises through its main business segments: Cloud and License, Hardware, and Services. The company is based in Austin, Texas, and was founded in June 1977 by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates.

READ NEXT: 7 Underperforming Data Centre Stocks to Buy According to Short Sellers and Top 10 Extreme Value Stocks To Buy Now.

Disclosure: None. Follow Insider Monkey on Google News.